By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo

TheMediTary.Com

Medical Information, Documents, News - TheMediTary.Com

  • Home
  • News
  • Drugs
  • Drugs A-Z
  • Medical Answers
  • About Us
  • Contact
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo
Search Drugs
  • Drugs
    • Latest Drugs
    • Drugs A-Z
    • Medical Answers
  • News
    • FDA Alerts
    • Medical News
    • Health
    • Consumer Updates
    • Children's Health
  • More TheMediTary.Com
    • About Us
    • Contact
Follow US
Home > Drugs > Skeletal muscle relaxants > Cyclobenzaprine > Cyclobenzaprine Dosage
Skeletal muscle relaxants
https://themeditary.com/dosage-information/cyclobenzaprine-dosage-253.html

Cyclobenzaprine Dosage

Drug Detail:Cyclobenzaprine (Cyclobenzaprine [ sye-kloe-ben-za-preen ])

Drug Class: Skeletal muscle relaxants

Contents
Uses Warnings Before Taking Dosage Side effects Interactions FAQ

Usual Adult Dose for Muscle Spasm

Immediate-release:
Initial dose: 5 mg orally 3 times a day

  • May increase to 10 mg orally 3 times a day based on individual patient response
Duration of therapy: Up to 3 weeks

Extended-release:
Initial dose: 15 mg orally once a day
  • May increase to 30 mg orally based on individual patient response
Duration of therapy: Up to 3 weeks

Comments:
  • Duration of therapy should be limited to 2 to 3 weeks.
  • Response is measured by relief of muscle spasm and its associated signs and symptoms, namely pain, tenderness, and limitation of motion.

Use: As an adjunct to rest and physical therapy for relief of muscle spasm associated with acute, painful musculoskeletal conditions.

Usual Geriatric Dose for Muscle Spasm

Immediate-release:
Initial dose: 5 mg orally up to 3 times a day
Duration of therapy: Duration of therapy: Up to 3 weeks

Extended-release: Not recommended

Comments:

  • Due to higher plasma levels in elderly patients, less frequent dosing should be considered.
  • Extended-release capsules are not recommended in elderly patients.
  • Duration of therapy should be limited to 2 to 3 weeks.

Use: As an adjunct to rest and physical therapy for relief of muscle spasm associated with acute, painful musculoskeletal conditions.

Usual Pediatric Dose for Muscle Spasm

15 years and older:
Immediate-release:
Initial dose: 5 mg orally 3 times a day

  • May increase to 10 mg orally 3 times a day based on individual patient response
Duration of therapy: Up to 3 weeks

Extended-release: Safety and effectiveness has not been established

Comments:
  • Duration of therapy should be limited to 2 to 3 weeks.
  • Response is measured by relief of muscle spasm and its associated signs and symptoms, namely pain, tenderness, and limitation of motion.

Use: As an adjunct to rest and physical therapy for relief of muscle spasm associated with acute, painful musculoskeletal conditions.

Renal Dose Adjustments

No adjustment recommended

Liver Dose Adjustments

Immediate-release:
Mild hepatic impairment:

  • Initial dose: 5 mg orally; titrate slowly upward

Moderate to severe hepatic impairment: Not recommended

Extended-release: Not recommended

Precautions

Safety and efficacy of immediate-release product have not been established in patients younger than 15 years.

Safety and efficacy of extended-release product have not been established in patients younger than 18 years.

Consult WARNINGS section for additional precautions.

Dialysis

Data not available

Other Comments

Administration advice:

  • Take orally for up to 3 week's duration

Extended-release:
  • Take at approximately the same time each day
  • Swallow whole
  • Alternatively, open capsule and sprinkle contents of capsule over 1 tablespoon of applesauce; consume immediately without chewing; rinse mouth to ensure all contents have been swallowed

Storage:
  • Protect from light

General:
  • This drug is ineffective in muscle spasm due to CNS disease including cerebral or spinal cord disease, or in children with cerebral palsy.
  • Evidence of effectiveness beyond 2 to 3 weeks is not available; additionally, muscle spasms associated with acute, painful musculoskeletal conditions are generally of short duration.

Monitoring:
  • Response to therapy is measured by relief of muscle spasm and its associated signs and symptoms, namely pain, tenderness, and limitation of motion.
  • Monitor for anticholinergic toxicity
  • Monitor for the development of serotonin syndrome in those patients on concomitant serotonergic drugs.

Patient advice:
  • Patients should understand that this drug should be used for short periods along with rest and physical therapy.
  • Patients should be informed that this drug may impair their ability to perform hazardous task such as driving and they should not undertake such tasks until they know how this drug affects them.
  • Alcohol and other CNS depressants may enhance the impairment effects of this drug.
  • Patients on concomitant serotonergic drugs should know the signs and symptoms of serotonin syndrome and when it is necessary to seek medical attention.

Frequently asked questions

  • How much cyclobenzaprine can I take?
  • Can antidepressants be used for arthritis pain?
  • How long does it take for Flexeril to work?
  • Is cyclobenzaprine a controlled substance or addictive?
  • How long does Flexeril stay in your system?
  • Can I take cyclobenzaprine and Tylenol together?
Share this Article
Latest News
Medical News

Shingles vaccine may lower heart disease risk by up to 8 years

May 09, 2025
Obesity, unhealthy lifestyles may cause heart to age by 5–45 years
Aging: As little as 5 minutes of exercise may keep the brain healthy
Prostate cancer: Simple urine test may help with early detection
Cancer treatment side effects: Exercise may reduce pain, fatigue
Alzheimer's: Exercising in middle age may reduce beta-amyloid in brain...
Related Drugs
Fidanacogene Elaparvovec
Cerave Anti-Itch
Centrum Adult
Crovalimab
Cyltezo Prefilled Syringe
Zepbound Pen
Mylanta One
Uretron Ds
Medihoney Wound And Burn Dressing
Lidotrode

Other drugs

Name Drug Class Updated
Fidanacogene Elaparvovec Drugs 03-Oct-2024
Cerave Anti-Itch Drugs 02-Oct-2024
Centrum Adult Drugs 02-Oct-2024
Crovalimab Drugs 02-Oct-2024
Cyltezo Prefilled Syringe Drugs 01-Oct-2024
Zepbound Pen Drugs 30-Sep-2024
Mylanta One Drugs 27-Sep-2024
Uretron Ds Drugs 27-Sep-2024
Medihoney Wound And Burn Dressing Drugs 26-Sep-2024
Lidotrode Drugs 26-Sep-2024
Libervant Drugs 26-Sep-2024
Moderna Covid-19 Drugs 25-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024

Categories

  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health

About US

Welcome to TheMediTary.Com

Our website provides reliable and up-to-date information on various medical topics. We empower individuals to take charge of their health by simplifying complex medical jargon and providing practical tips and advice. We prioritize the privacy and confidentiality of our users and welcome feedback to improve our services.

Website use data of FDA and other sources

DMCA.com Protection Status Truste Protection Status Trust Mark Protection Status
HONcode logo We comply with the HONcode standard for trustworthy health information.
Quick Link
  • About Us
  • Contact Us
  • Editorial Policy
  • Privacy Policy
  • Accessibility Policy
  • Terms & Conditions
  • Disclaimer
  • DMCA
  • Do Not Sell My Personal Information
  • Sitemap
  • Care Notes
  • Health Guide
  • Professional
Drugs
  • New Drugs
  • Medical Answers
  • Drugs A-Z
  • Drug Classes
  • Drug Dosage
  • Pill Identifier
  • Consumer Infor
  • Side Effects
  • Inactive Ingredients
  • Pregnancy Warnings
  • Patient Tips
  • Treatments
News
  • Latest News
  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health
Find US
  • Medium
  • Google Site
  • Blogspot
  • API
  • Reddit
  • Tumblr
  • Scoop.it
  • Substack
  • Wordpress
  • Wix
  • Behance

© 2025 TheMediTary.Com All rights reserved. Operated by